Geode Capital Management, LLC Hepion Pharmaceuticals, Inc. Transaction History

Geode Capital Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.27 - $11.9 $447 - $19,718	-1,657 Reduced 0.25%	656,453 $197,000
Q3 2021 Nov 12, 2021	BUY	$1.39 - $2.1 $9,440 - $14,263	6,792 Added 1.04%	658,110 $1.01 Million
Q2 2021 Aug 13, 2021	BUY	$1.56 - $2.26 $97,656 - $141,476	62,600 Added 10.63%	651,318 $1.29 Million
Q1 2021 May 12, 2021	BUY	$1.77 - $2.98 $683,508 - $1.15 Million	386,163 Added 190.65%	588,718 $1.08 Million
Q4 2020 Feb 12, 2021	BUY	$1.58 - $3.64 $295,095 - $679,839	186,769 Added 1183.13%	202,555 $443,000
Q3 2020 Nov 13, 2020	BUY	$2.84 - $4.59 $44,832 - $72,457	15,786 New	15,786 $49,000
Q1 2020 May 14, 2020	SELL	$1.15 - $5.74 $16,016 - $79,940	-13,927 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$2.25 - $6.99 $31,335 - $97,349	13,927 New	13,927 $74,000

Ticker HEPA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,229,600
Market Cap $51.8M
Description
Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It is involved in developing Rencofilstat, a cyclophilin inhibitor that has completed Phase 2a clinical trials to target multiple pathologic pathways involved in the progression of liver...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.